We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
-3.71%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.59%
AUM
$797M
AUM Growth
-$50M
Cap. Flow
-$11M
Cap. Flow %
-1.38%
Top 10 Hldgs %
35.2%
Holding
175
New
5
Increased
39
Reduced
64
Closed
7

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$1.42M
2
CVX icon
Chevron
CVX
+$817K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$737K
4
HRMY icon
Harmony Biosciences
HRMY
+$408K
5
FLS icon
Flowserve
FLS
+$313K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.8M
2
CVS icon
CVS Health
CVS
+$2.35M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.46M
4
NVDA icon
NVIDIA
NVDA
+$1.21M
5
PDCE
PDC Energy, Inc.
PDCE
+$1.07M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Healthcare 19.84%
3 Consumer Discretionary 9.26%
4 Industrials 7.51%
5 Consumer Staples 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMT icon
126
American Tower
AMT
$80.4B
$403K 0.05%
2,453
– –
GEHC icon
127
GE HealthCare
GEHC
$32.4B
$403K 0.05%
5,928
-23
-0.4% -$1.67K
BP icon
128
BP
BP
$107B
$386K 0.05%
9,965
-1,225
-11% -$45.5K
HRMY icon
129
Harmony Biosciences
HRMY
$2.24B
$385K 0.05%
+11,761
New +$408K
FCX icon
130
Freeport-McMoran
FCX
$97.5B
$381K 0.05%
10,204
– –
AWK icon
131
American Water Works
AWK
$26.9B
$363K 0.05%
2,930
– –
AYX
132
DELISTED
Alteryx Inc
AYX
$356K 0.04%
9,442
– –
MA icon
133
Mastercard
MA
$493B
$338K 0.04%
853
– –
BABA icon
134
Alibaba
BABA
$308B
$330K 0.04%
3,803
– –
BA icon
135
Boeing
BA
$185B
$323K 0.04%
1,686
– –
LIN icon
136
Linde
LIN
$226B
$295K 0.04%
793
– –
NTLA icon
137
Intellia Therapeutics
NTLA
$1.67B
$285K 0.04%
9,002
– –
ELV icon
138
Elevance Health
ELV
$85.5B
$279K 0.03%
640
– –
OXY icon
139
Occidental Petroleum
OXY
$55.9B
$273K 0.03%
4,214
-14
-0.3% -$881
CTSH icon
140
Cognizant
CTSH
$26B
$258K 0.03%
3,802
– –
TROW icon
141
T. Rowe Price
TROW
$24.3B
$256K 0.03%
2,445
– –
PTEN icon
142
Patterson-UTI
PTEN
$3.76B
$256K 0.03%
18,466
– –
WSO icon
143
Watsco Inc
WSO
$13.6B
$255K 0.03%
675
– –
T icon
144
AT&T
T
$163B
$254K 0.03%
16,880
-850
-5% -$12.5K
WBA
145
DELISTED
Walgreens Boots Alliance
WBA
$252K 0.03%
11,311
-880
-7% -$23.4K
AFL icon
146
Aflac
AFL
$62.6B
$246K 0.03%
3,200
– –
VTI icon
147
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$244K 0.03%
1,150
– –
IBM icon
148
IBM
IBM
$224B
$230K 0.03%
1,637
– –
EQT icon
149
EQT Corp
EQT
$32.3B
$223K 0.03%
5,500
– –
RMD icon
150
ResMed
RMD
$30.7B
$223K 0.03%
1,505
– –
3 4 5
6
7

Similar funds

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Woodstock Corp's Q3 2023 Portfolio in Review

As of Q3 2023, Woodstock Corp held 175 positions worth $797M, down 5.9% from $847M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Woodstock Corp's Q3 2023 filing shows 5 new, 39 increased, 64 reduced and 7 closed positions. Its largest new stake was Harmony Biosciences: 11,761 shares worth $385K. The largest sale was Bristol-Myers Squibb, an estimated $2.8M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Woodstock Corp's largest Q3 2023 buy was Harmony Biosciences: 11,761 shares worth $385K.
  • Woodstock Corp added most to DexCom in Q3 2023, an estimated $1.42M increase.
  • Woodstock Corp's biggest Q3 2023 reduction was Bristol-Myers Squibb, cutting an estimated $2.8M.
  • Woodstock Corp fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $1.46M.
  • Woodstock Corp's ten largest holdings make up 35% of its $797M portfolio in Q3 2023.
  • Woodstock Corp opened 5 new positions and closed 7 in Q3 2023.
  • Woodstock Corp's portfolio value fell 5.9% quarter-over-quarter to $797M.

Based on Woodstock Corp's 13F filing for Q3 2023, filed 10 Oct 2023.